RedHill Biopharma (RDHL) Goodwill & Intangibles (2011 - 2025)
RedHill Biopharma (RDHL) posted quarterly Goodwill & Intangibles of $5.3 million for Q4 2025, down 4.62% year-over-year from $5.5 million in Q4 2024, and down 4.34% quarter-over-quarter from $5.5 million in Q2 2025.
RedHill Biopharma (RDHL) Goodwill & Intangibles (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Goodwill & Intangibles for 15 consecutive years, with $5.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Goodwill & Intangibles fell 4.62% year-over-year to $5.3 million; the TTM figure through Dec 2025 stood at $5.3 million (down 4.62% YoY), while the FY2025 annual figure was $5.3 million, down 4.62% from the prior year.
- Goodwill & Intangibles retreated to $5.3 million in Q4 2025 per RDHL's latest filing, from $5.5 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $89.4 million in Q4 2021 and bottomed at -$11.8 million in Q4 2023.
- Historically, Goodwill & Intangibles has averaged $43.9 million across 5 years, with a median of $67.1 million in 2022.
- Annual changes were most pronounced in 2021 — Goodwill & Intangibles soared 442.88% — and 2023, when it tumbled 113.19%.
- RedHill Biopharma's Goodwill & Intangibles stood at $89.4 million in 2021, then changed by 0.0% to $89.4 million in 2022, then sank by 113.19% to -$11.8 million in 2023, then soared by 147.06% to $5.5 million in 2024, then slipped by 4.62% to $5.3 million in 2025.
- Business Quant data shows RDHL's Goodwill & Intangibles at $5.3 million in Q4 2025, $5.5 million in Q2 2025, and $5.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.29 Mn |
| Jun 30, 2025 | 5.53 Mn |
| Dec 31, 2024 | 5.55 Mn |
| Jun 30, 2024 | 5.56 Mn |
| Dec 31, 2023 | -11.79 Mn |
| Jun 30, 2023 | 5.59 Mn |
| Mar 31, 2023 | 5.60 Mn |
| Dec 31, 2022 | 89.37 Mn |
| Sep 30, 2022 | 67.14 Mn |
| Jun 30, 2022 | 68.74 Mn |
| Mar 31, 2022 | 70.04 Mn |
| Dec 31, 2021 | 89.37 Mn |
| Sep 30, 2021 | 82.39 Mn |
| Jun 30, 2021 | 84.22 Mn |
| Mar 31, 2021 | 86.05 Mn |
| Dec 31, 2020 | 89.37 Mn |
| Sep 30, 2020 | 89.96 Mn |
| Jun 30, 2020 | 79.52 Mn |
| Mar 31, 2020 | 15.85 Mn |
| Dec 31, 2019 | 11.79 Mn |